Viewing Study NCT03825367

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:38 AM
Ignite Modification Date: 2026-02-02 @ 6:23 PM
Study NCT ID: NCT03825367
Status: UNKNOWN
Last Update Posted: 2022-10-12
First Post: 2019-01-28
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Nivolumab in Combination With 5-azacytidine in Childhood Relapsed/Refractory AML
Sponsor: Therapeutic Advances in Childhood Leukemia Consortium
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None AML, Childhood View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Relapse View
None Refractory View
None Leukemia View
None Acute View
None Pediatric View
None nivolumab View
None azacytidine View